T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
15 mai 2024 07h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock
14 mai 2024 17h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
07 mai 2024 09h00 HE
|
T2 Biosystems, Inc.
Filed Pursuant to Rule 433Issuer Free Writing Prospectus dated May 6, 2024Relating to Preliminary Prospectus dated May 6, 2024Registration No. 333-278866 LEXINGTON, Mass., May 07, 2024 (GLOBE...
T2 Biosystems Announces First Quarter 2024 Financial Results
06 mai 2024 16h34 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
06 mai 2024 16h34 HE
|
T2 Biosystems, Inc.
Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No. 333-278866 LEXINGTON, Mass., May 06, 2024 (GLOBE...
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
06 mai 2024 16h29 HE
|
T2 Biosystems, Inc.
Filed Pursuant to Rule 433Issuer Free Writing Prospectus dated May 6, 2024Relating to Preliminary Prospectus dated May 6, 2024Registration No. 333-278866 LEXINGTON, Mass., May 06, 2024 (GLOBE...
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
24 avr. 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
11 avr. 2024 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
28 mars 2024 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
20 mars 2024 07h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...